IBTA e-News February 2017 released

By 28th February 2017IBTA News
[31 February 2017] The IBTA's monthly e-News has now been released and has been emailed to all subscribers. To sign up to receive your copy, click here.

Some of the highlights from this month's include:

  • The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group is developing computerised adaptive testing (CAT) versions of the EORTC Quality of Life Questionnaire (EORTC QLQ-C30) to be used in clinical practice
  • In work published in Science Translational Medicine, researchers have demonstrated that human skin cells can be reprogrammed using ‘skin flipping’ technology into modified stem cells which target and destroy glioblastoma tumour cells.
  • Results from a clinical study has shown that testing paediatric brain tumours for genetic abnormalities near the time of diagnosis is feasible and could play a role in guiding patients’ treatment.
  • A team in Australia has developed a surgical probe that contains a fibre-optic camera the size of a human hair, which allows surgeons to ‘see’ important blood vessels while taking a brain biopsy.
  • A genetic analysis of 775 meningioma tumours published in Nature Communications has identified several genetic features that distinguish atypical meningiomas - those which often grow aggressively and recur after removal - from benign meningiomas.
  • An article in Neuro-Oncology Practice discusses the role that cannabinoids – drugs derived from chemicals in the cannabis plant – may have in brain tumour palliative care.
  • The start of March marks Brain Tumour Awareness Month in the UK. Charities, groups and individuals across the country will be using the opportunity to highlight the importance of brain tumour research, improved treatment and support to the general public and to fundraise.
  • You can read the IBTA e-News February 2017 edition in full online here. You can sign up to receive the e-News every month by registering here.

Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 7,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences.

To see an archive of existing e-News issues, click here.

Subscribe to IBTA's e-News!